Adherence and Persistence

Panelists discuss how adherence to low-density lipoprotein (LDL)–lowering therapy, particularly injectables, remains one of the greatest challenges to long-term success. Patients often discontinue treatment due to side effects, inconvenience, or lack of follow-up support.

Pharmacists and health systems can play a key role in monitoring persistence, providing reminders, and counseling patients about the benefits of sustained therapy.

Panelists emphasize that simplifying treatment regimens and enhancing digital engagement could improve adherence and outcomes.